LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Linville Retires, Remains iMDS Board Chair
People In The News

Linville Retires, Remains iMDS Board Chair

May 8, 2011 1 min read Premium comments

Advertisement

Linville Retires, Remains iMDS Board Chair
Harold Linville

After 33 years of service as Chief Business Development Officer for Innovative Medical Device Solutions (iMDS) Harold Linville is retiring. He will continue to serve as Chairman of the Board of the company. Linville was President and CEO of iMDS during the 2007 merger of Leis Medical with Medicine Lodge. His retirement from day-to-day responsibilities will become effective on September 5, 2011.

“Harold has played a key role in our history of success, ” said Brady Shirley, iMDS President and CEO. “He will continue to make a significant impact on our future as Chairman of the Board.”

Prior to his position at iMDS, Linville was President and Chief Executive Office of Leis Medical (now iMDS Product Sourcing) where he managed all aspects of the manufacturing operations . Linville, who has extensive sales and operations experience, was actively involved in workforce development and served on numerous advisory boards and committees.

Colleagues praise him for his “true passion for our industry as well as his fierce loyalty and commitment to Dayton, Ohio, and Dayton manufacturing. Harold is a great mentor and truly inspirational.”

iMDS is a medical device outsourcing company that provides contract medical device development, manufacturing and supply chain management for customers in the United States and internationally.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy